Hagendorf, A.

glucocorticoid receptor patient fatigue biliary cirrhosis expression hgr mrna variant disease study glucocorticoid resistance glucocorticoid receptor level sclerosing cholangitis cirrhosis biliary glucocorticoid receptor variants pilot study activity hgr p resistance cholestatic liver diseases glucocorticoid receptor beta correlation control effect sclerosing cholangiti severity hgr expression liver disease activity serum activity serum phosphatase coeff ursodeoxycholic acid hgr variant pilot cholestatic liver disease hgr mrna levels blood cytokine cidlowski ja mechanism cholestatic domain ffss table result nonfatigued patients relation abnormality arthritis value addition scale domain sample hgr protein levels october hgr p variants number analogue scale ursodeoxycholic prognostic factors hgr p mrna glucocorticoid treatment hgr levels treatment asthma ter borg analysis isoform marker encoding ratio beta-isoform difference cidlowski analogue